Silas Adjei
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Silas Adjei has a total of 46 co-authors. Here are the top co-authors by number of shared publications:
- Isaac Kingsley Amponsah
Kwame Nkrumah University of Science and Technology
6 shared publications - Abraham Yeboah Mensah
Kwame Nkrumah University of Science and Technology
3 shared publications - Emmanuel Quaye Kontoh
Kwame Nkrumah University of Science and Technology
3 shared publications Evelyn Asante-Kwatia
Kwame Nkrumah University of Science and Technology
3 shared publications- Reinhard Isaac Nketia
University of Cape Coast
3 shared publications - Akwasi Acheampong
Department of Chemistry, Kwame Nkrumah University of Science and Technology, Kumasi, Ghana
2 shared publications
Latest Publications
- Open Access
- 28 September 2026
- Published by SAGE Publications in Natural Product Communications
- Vol. 21 (9)
Antimalarial Potential of the Stem Bark of Amphimas pterocarpoides (DC.) Harms: In vivo Antimalarial Activity of Hydroethanol Extract and In Vitro Antiplasmodial Activity of Bioactive Constituents
Objective: This study evaluated the antimalarial activity of the stem bark extract of Amphimas pterocarpoides , isolated bioactive compounds from its most active fraction, and assessed the interactions of these constituents with the Plasmodium falciparum lactate dehydrogenase (pfLDH) in silico. Methods: The acute oral toxicity of the crude extract was assessed in accordance with OECD Guideline 425. In vitro antiplasmodial and erythrocyte compatibility were determined using SYBR Green and MTT assays, respectively. In vivo antimalarial activity was assessed in Plasmodium berghei -infected mice using Peter’s suppressive and Rane’s curative models. Blind molecular docking analysis was used to predict the compound’s interaction with pfLDH. Results: The extract demonstrated promising antiplasmodial activity against the P. falciparum 3D7, K1, and Dd2 strains (IC 50 = 0.771–1.861 μg/mL) and exhibited favourable RBC compatibility, with CC 50 values >80 μg/mL, comparable to those observed for artesunate. The crude extract showed no signs of toxicity at 2000 mg/kg and exhibited significant chemosuppression (84.64 ± 0.47% and 79.37 ± 0.98%) in both in vivo models. Additionally, the extract prevented Plasmodium-induced weight loss, PCV reduction, and hypothermia. Chromatographic fractionation of the most active fraction yielded three compounds: Betulinic acid, 6-methoxyisofomononetin and daucosterol. All isolates and artesunate exhibited appreciable activity against Plasmodium falciparum strains (IC 50 = 0.25–1.13 μM) with erythrocyte selectivity indices >70. Also, all compounds exhibited more favourable predictive interactions with pfLDH than chloroquine did. Conclusion: The crude extract of A. pterocarpoides showed antimalarial potential against chloroquine-sensitive and resistant Plasmodium falciparum strains. To the best of our knowledge, this is the first report of the antiplasmodial activity of 6-methoxyisoformononetin and its interaction with pfLDH.
- 28 September 2026
- Published by SAGE Publications in Natural Product Communications
- Vol. 21 (9)
Open AccessAntimalarial Potential of the Stem Bark of Amphimas pterocarpoides (DC.) Harms: In vivo Antimalarial Activity of Hydroethanol Extract and In Vitro Antiplasmodial Activity of Bioactive Constituents
Objective: This study evaluated the antimalarial activity of the stem bark extract of Amphimas pterocarpoides , isolated bioactive compounds from its most active fraction, and assessed the interactions of these constituents with the Plasmodium falciparum lactate dehydrogenase (pfLDH) in silico. Methods: The acute oral toxicity of the crude extract was assessed in accordance with OECD Guideline 425. In vitro antiplasmodial and erythrocyte compatibility were determined using SYBR Green and MTT assays, respectively. In vivo antimalarial activity was assessed in Plasmodium berghei -infected mice using Peter’s suppressive and Rane’s curative models. Blind molecular docking analysis was used to predict the compound’s interaction with pfLDH. Results: The extract demonstrated promising antiplasmodial activity against the P. falciparum 3D7, K1, and Dd2 strains (IC 50 = 0.771–1.861 μg/mL) and exhibited favourable RBC compatibility, with CC 50 values >80 μg/mL, comparable to those observed for artesunate. The crude extract showed no signs of toxicity at 2000 mg/kg and exhibited significant chemosuppression (84.64 ± 0.47% and 79.37 ± 0.98%) in both in vivo models. Additionally, the extract prevented Plasmodium-induced weight loss, PCV reduction, and hypothermia. Chromatographic fractionation of the most active fraction yielded three compounds: Betulinic acid, 6-methoxyisofomononetin and daucosterol. All isolates and artesunate exhibited appreciable activity against Plasmodium falciparum strains (IC 50 = 0.25–1.13 μM) with erythrocyte selectivity indices >70. Also, all compounds exhibited more favourable predictive interactions with pfLDH than chloroquine did. Conclusion: The crude extract of A. pterocarpoides showed antimalarial potential against chloroquine-sensitive and resistant Plasmodium falciparum strains. To the best of our knowledge, this is the first report of the antiplasmodial activity of 6-methoxyisoformononetin and its interaction with pfLDH.
- Open Access
- 27 May 2026
- Published by SAGE Publications in Natural Product Communications
- Vol. 21 (5)
Antimalarial Potential of Phragmanthera capitata : An Insight Into the Activity of Its Extracts and Isolated Compounds
Objective: This study aimed to evaluate the antimalarial activity of the extracts and isolated compounds from the stem of Phragmanthera capitata . Methods: Aqueous and methanol extracts were prepared from the stem of the plant. The methanol extract was purified via column chromatography to yield friedelin, friedelinol, β-sitosterol and daucosterol. The in vitro anti-plasmodial activity of the extracts and isolated compounds was evaluated against chloroquine-sensitive (3D7) and resistant (Dd2) strains of P. falciparum using the SYBR Green assay and, in vivo antimalarial activity via the Peters’ and Rane’s tests. Results: The methanol extract demonstrated superior activity over the aqueous extract, with IC 50 values of 0.84 (3D7) and 1.92 µg/mL (Dd2) in the in vitro antiplasmodial assay. Similarly, daucosterol was the most active compound among the isolated compounds with IC 50 values of 0.84 (3D7) and 2.05 μg/mL (Dd2). The aqueous and the methanol extracts showed comparable suppressive activities in the Peters’ assay with 88% and 89% parasitaemia suppression, respectively. The aqueous extract was more active in the Rane’s curative assay, with 89 % parasitaemia suppression. Friedelin and β-sitosterol displayed similar and remarkable curative potential in the Rane’s assay with % parasitaemia suppression of 85.66 and 86.49, respectively. Conclusion: This study validates the Phragmanthera capitata extracts and isolated compounds as antimalarial agents, rationalising the traditional use of the plant to treat malaria. Future work could consider development into antimalarial products, which would contribute to SDG 3 and the Universal Health coverage.
- 27 May 2026
- Published by SAGE Publications in Natural Product Communications
- Vol. 21 (5)
Open AccessAntimalarial Potential of Phragmanthera capitata : An Insight Into the Activity of Its Extracts and Isolated Compounds
Objective: This study aimed to evaluate the antimalarial activity of the extracts and isolated compounds from the stem of Phragmanthera capitata . Methods: Aqueous and methanol extracts were prepared from the stem of the plant. The methanol extract was purified via column chromatography to yield friedelin, friedelinol, β-sitosterol and daucosterol. The in vitro anti-plasmodial activity of the extracts and isolated compounds was evaluated against chloroquine-sensitive (3D7) and resistant (Dd2) strains of P. falciparum using the SYBR Green assay and, in vivo antimalarial activity via the Peters’ and Rane’s tests. Results: The methanol extract demonstrated superior activity over the aqueous extract, with IC 50 values of 0.84 (3D7) and 1.92 µg/mL (Dd2) in the in vitro antiplasmodial assay. Similarly, daucosterol was the most active compound among the isolated compounds with IC 50 values of 0.84 (3D7) and 2.05 μg/mL (Dd2). The aqueous and the methanol extracts showed comparable suppressive activities in the Peters’ assay with 88% and 89% parasitaemia suppression, respectively. The aqueous extract was more active in the Rane’s curative assay, with 89 % parasitaemia suppression. Friedelin and β-sitosterol displayed similar and remarkable curative potential in the Rane’s assay with % parasitaemia suppression of 85.66 and 86.49, respectively. Conclusion: This study validates the Phragmanthera capitata extracts and isolated compounds as antimalarial agents, rationalising the traditional use of the plant to treat malaria. Future work could consider development into antimalarial products, which would contribute to SDG 3 and the Universal Health coverage.
- Open Access
- 9 January 2025
- Published by SAGE Publications in Natural Product Communications
- Vol. 20 (1)
Assessment of Wound Healing Properties of Medicinal Plants: The Case of Berlinia confusa
Objectives: Berlinia confusa is used as wound healing agent in folklore medicine. However, this has not been scientifically validated and there is dearth of information on its bioactive metabolites. The current research aimed at evaluating the wound healing, antioxidant and antimicrobial activities of the stem bark of the plant and track down some of its metabolites. Methods: The dermal excision model in Sprague Dawley rats was used for the in vivo wound healing activity of the 70% ethanol extract (formulated as 1% and 2% cream). The DPPH radical scavenging and in-vivo lipid peroxidation assays were used to assess the antioxidant activity whereas the agar well and broth-dilution assays were used for the antimicrobial activity evaluation. The PrestoBlue cell viability in keratinocytes and acute dermal toxicity assays were used for the safety assessment. Results: The 1% w/w extract showed over 70% wound surface closure from day 13-23 whereas the 2% w/w exhibited similar effect from day 15-23. The activity of the extract was comparable to 1% silver sulphadiazine (SSD) used as reference agent. The extract (1% w/w) also significantly reduced malondialdehyde (MDA) levels (455.2 ± 11.91) compared to the negative control group (739.8 ± 44.93) and was also superior to silver sulphadiazine (MDA level 548.4 ± 10.73). The extract again showed a considerable antimicrobial activity against pathogenic microorganisms with MIC's in the range of 5-10 mg/mL. The 2% extract did not show any skin irritation and were mildly toxic (88.2 ± 3.76% viability) to keratinocytes. Purification of the extract yielded two (2) major known wound healing metabolites including betulinic acid and catechin. Conclusion: Berlinia confusa has demonstrated considerable wound healing in vivo and also mitigated healing modifying factors such as microbes and reactive oxygen species.
- 9 January 2025
- Published by SAGE Publications in Natural Product Communications
- Vol. 20 (1)
Open AccessAssessment of Wound Healing Properties of Medicinal Plants: The Case of Berlinia confusa
Objectives: Berlinia confusa is used as wound healing agent in folklore medicine. However, this has not been scientifically validated and there is dearth of information on its bioactive metabolites. The current research aimed at evaluating the wound healing, antioxidant and antimicrobial activities of the stem bark of the plant and track down some of its metabolites. Methods: The dermal excision model in Sprague Dawley rats was used for the in vivo wound healing activity of the 70% ethanol extract (formulated as 1% and 2% cream). The DPPH radical scavenging and in-vivo lipid peroxidation assays were used to assess the antioxidant activity whereas the agar well and broth-dilution assays were used for the antimicrobial activity evaluation. The PrestoBlue cell viability in keratinocytes and acute dermal toxicity assays were used for the safety assessment. Results: The 1% w/w extract showed over 70% wound surface closure from day 13-23 whereas the 2% w/w exhibited similar effect from day 15-23. The activity of the extract was comparable to 1% silver sulphadiazine (SSD) used as reference agent. The extract (1% w/w) also significantly reduced malondialdehyde (MDA) levels (455.2 ± 11.91) compared to the negative control group (739.8 ± 44.93) and was also superior to silver sulphadiazine (MDA level 548.4 ± 10.73). The extract again showed a considerable antimicrobial activity against pathogenic microorganisms with MIC's in the range of 5-10 mg/mL. The 2% extract did not show any skin irritation and were mildly toxic (88.2 ± 3.76% viability) to keratinocytes. Purification of the extract yielded two (2) major known wound healing metabolites including betulinic acid and catechin. Conclusion: Berlinia confusa has demonstrated considerable wound healing in vivo and also mitigated healing modifying factors such as microbes and reactive oxygen species.
- Open Access
- 1 January 2024
- Published by Wiley in International Journal of Food Science
- Vol. 2024 (1) , 8285434
Quality Assessment of Tomato Paste Products on the Ghanaian Market: An Insight Into Their Possible Adulteration
Tomato paste is the most consumed tomato product on the Ghanaian market, the majority of which are imported into the country. This food product is easily adulterated, and thus, routine quality checks are necessary. Therefore, the current study is aimed at assessing the quality of eight tomato paste products on the Ghanaian market and checking for the presence of starch and artificial colourant erythrosine as possible adulterants. Routine quality metrics such as the pH, titratable acidity, total solids, and total soluble solids were assessed using standard methods. An HPLC method was employed to detect the presence of the colourant erythrosine, whereas starch content was determined by an enzymatic method using α‐amylase and then amyloglucosidase. Fifty percent of the products did not qualify to be called tomato paste based on total solid estimation. All the sampled products contained some amount of starch, with three having more than 10 g/100 g of this thickener. Additionally, the banned colourant erythrosine was detected in two of the products. All other parameters were consistent with regulatory standards. The present study has shown that some tomato paste products on the Ghanaian market contain additives that are not permitted under any circumstance and fall short of regulatory standards.
- 1 January 2024
- Published by Wiley in International Journal of Food Science
- Vol. 2024 (1) , 8285434
Open AccessQuality Assessment of Tomato Paste Products on the Ghanaian Market: An Insight Into Their Possible Adulteration
Tomato paste is the most consumed tomato product on the Ghanaian market, the majority of which are imported into the country. This food product is easily adulterated, and thus, routine quality checks are necessary. Therefore, the current study is aimed at assessing the quality of eight tomato paste products on the Ghanaian market and checking for the presence of starch and artificial colourant erythrosine as possible adulterants. Routine quality metrics such as the pH, titratable acidity, total solids, and total soluble solids were assessed using standard methods. An HPLC method was employed to detect the presence of the colourant erythrosine, whereas starch content was determined by an enzymatic method using α‐amylase and then amyloglucosidase. Fifty percent of the products did not qualify to be called tomato paste based on total solid estimation. All the sampled products contained some amount of starch, with three having more than 10 g/100 g of this thickener. Additionally, the banned colourant erythrosine was detected in two of the products. All other parameters were consistent with regulatory standards. The present study has shown that some tomato paste products on the Ghanaian market contain additives that are not permitted under any circumstance and fall short of regulatory standards.
- Open Access
- 21 October 2021
- Published by Wiley in The Scientific World Journal
- Vol. 2021, 1-10
Antibacterial, Antibiofilm, and Efflux Pump Inhibitory Properties of the Crude Extract and Fractions from Acacia macrostachya Stem Bark
Microbial infections remain a public health problem due to the upsurge of bacterial resistance. In this study, the antibacterial, antibiofilm, and efflux pump inhibitory activities of the stem bark of Acacia macrostachya, an indigenous African medicinal plant, were investigated. In traditional medicine, the plant is used in the treatment of microbial infections and inflammatory conditions. A crude methanol extract obtained by Soxhlet extraction was partitioned by column chromatography to obtain the petroleum ether, ethyl acetate, and methanol fractions. Antibacterial, efflux pump inhibition and antibiofilm formation activities were assessed by the high-throughput spot culture growth inhibition (HT-SPOTi), ethidium bromide accumulation, and the crystal violet retention assay, respectively. The minimum inhibitory concentrations (MICs) of the crude extract and major fractions ranged from 250 to 500μg/mL. At a concentration of 3.9250μg/mL, all extracts demonstrated >80 inhibition of biofilm formation in S. aureus. In P. aeruginosa, the EtOAc fraction showed the highest antibiofilm activity (5969) while the pet-ether fraction was most active against E. coli biofilms (4567). Among the test samples, the crude extract, methanol, and ethyl acetate fractions showed remarkable efflux pump inhibition in S. aureus, E. coli, and P. aeruginosa. At ½ MIC, the methanol fraction demonstrated significant accumulation of EtBr in E. coli having superior efflux inhibition over the standard EPIs: chlorpromazine and verapamil. Tannins, flavonoids, triterpenoids, phytosterols, coumarins, and saponins were identified in preliminary phytochemical studies. Stigmasterol was identified in the EtOAc fraction. This study justifies the use of A. macrostachya in the treatment of infections in traditional medicine and highlights its potential as a source of bioactive compounds that could possibly interact with some resistance mechanisms in bacteria to combat antimicrobial resistance.
- 21 October 2021
- Published by Wiley in The Scientific World Journal
- Vol. 2021, 1-10
Open AccessAntibacterial, Antibiofilm, and Efflux Pump Inhibitory Properties of the Crude Extract and Fractions from Acacia macrostachya Stem Bark
Microbial infections remain a public health problem due to the upsurge of bacterial resistance. In this study, the antibacterial, antibiofilm, and efflux pump inhibitory activities of the stem bark of Acacia macrostachya, an indigenous African medicinal plant, were investigated. In traditional medicine, the plant is used in the treatment of microbial infections and inflammatory conditions. A crude methanol extract obtained by Soxhlet extraction was partitioned by column chromatography to obtain the petroleum ether, ethyl acetate, and methanol fractions. Antibacterial, efflux pump inhibition and antibiofilm formation activities were assessed by the high-throughput spot culture growth inhibition (HT-SPOTi), ethidium bromide accumulation, and the crystal violet retention assay, respectively. The minimum inhibitory concentrations (MICs) of the crude extract and major fractions ranged from 250 to 500μg/mL. At a concentration of 3.9250μg/mL, all extracts demonstrated >80 inhibition of biofilm formation in S. aureus. In P. aeruginosa, the EtOAc fraction showed the highest antibiofilm activity (5969) while the pet-ether fraction was most active against E. coli biofilms (4567). Among the test samples, the crude extract, methanol, and ethyl acetate fractions showed remarkable efflux pump inhibition in S. aureus, E. coli, and P. aeruginosa. At ½ MIC, the methanol fraction demonstrated significant accumulation of EtBr in E. coli having superior efflux inhibition over the standard EPIs: chlorpromazine and verapamil. Tannins, flavonoids, triterpenoids, phytosterols, coumarins, and saponins were identified in preliminary phytochemical studies. Stigmasterol was identified in the EtOAc fraction. This study justifies the use of A. macrostachya in the treatment of infections in traditional medicine and highlights its potential as a source of bioactive compounds that could possibly interact with some resistance mechanisms in bacteria to combat antimicrobial resistance.
- Open Access
- 1 January 2021
- Published by Elsevier in SSRN Electronic Journal
Fruits of Vitex Doniana Sweet: Toxicity Profile, Anti-Inflammatory and Antioxidant Activities, and Quantification of One of its Bioactive Constituents Oleanolic Acid
Background: Vitex doniana Sweet fruit, an under-utilised crop specie of Ghana, has not been validated for its ethnomedical use in managing inflammatory conditions. Therefore, the study sought to investigate its anti-inflammatory and antioxidant activities as well as isolate and quantify one of its active constituents. Methods: In-vivo anti-inflammatory assay was done using the carrageenan- induced oedema model in chicks. The in-vitro antioxidant property was also investigated using the 2, 2-diphenyl-1-picrylhydrayl radical scavenging assay. The acute and subacute toxicity studies of the fruit extract were evaluated in rodent models. Results: No signs of autonomic and central nervous system stimulation/depression were recorded. The median lethal dose (LD50 ), by oral route, was estimated to be beyond 3000 mg/kg body weight. Subacute studies revealed an increase in red blood cell and lymphocyte counts. Liver enzymes, serum proteins and bilirubin levels did not significantly increase. The crude extracts at doses of 10, 30 and 100 mg/kg inhibited paw oedema considerably. The ethyl acetate fraction showed the highest antioxidant activity (half-maximal inhibitory concentration, IC50 = 99.35 ± 0.77 µg/mL). 3β-hydroxyolean-12-en-28-oic acid (oleanolic acid), isolated from the ethyl acetate extract, showed significant anti-inflammatory and antioxidant activities. A sensitive high-performance liquid chromatography method for the detection and estimation of oleanolic acid, as a biomarker compound for V. doniana fruit, was developed and validated for quality assurance purposes. Conclusion: The extract of V. doniana possesses considerable anti-inflammatory and antioxidant properties and was non-toxic under laboratory conditions.
- 1 January 2021
- Published by Elsevier in SSRN Electronic Journal
Open AccessFruits of Vitex Doniana Sweet: Toxicity Profile, Anti-Inflammatory and Antioxidant Activities, and Quantification of One of its Bioactive Constituents Oleanolic Acid
Background: Vitex doniana Sweet fruit, an under-utilised crop specie of Ghana, has not been validated for its ethnomedical use in managing inflammatory conditions. Therefore, the study sought to investigate its anti-inflammatory and antioxidant activities as well as isolate and quantify one of its active constituents. Methods: In-vivo anti-inflammatory assay was done using the carrageenan- induced oedema model in chicks. The in-vitro antioxidant property was also investigated using the 2, 2-diphenyl-1-picrylhydrayl radical scavenging assay. The acute and subacute toxicity studies of the fruit extract were evaluated in rodent models. Results: No signs of autonomic and central nervous system stimulation/depression were recorded. The median lethal dose (LD50 ), by oral route, was estimated to be beyond 3000 mg/kg body weight. Subacute studies revealed an increase in red blood cell and lymphocyte counts. Liver enzymes, serum proteins and bilirubin levels did not significantly increase. The crude extracts at doses of 10, 30 and 100 mg/kg inhibited paw oedema considerably. The ethyl acetate fraction showed the highest antioxidant activity (half-maximal inhibitory concentration, IC50 = 99.35 ± 0.77 µg/mL). 3β-hydroxyolean-12-en-28-oic acid (oleanolic acid), isolated from the ethyl acetate extract, showed significant anti-inflammatory and antioxidant activities. A sensitive high-performance liquid chromatography method for the detection and estimation of oleanolic acid, as a biomarker compound for V. doniana fruit, was developed and validated for quality assurance purposes. Conclusion: The extract of V. doniana possesses considerable anti-inflammatory and antioxidant properties and was non-toxic under laboratory conditions.